PRESS RELEASE published on 01/22/2024 at 17:45, 10 months 30 days ago The Ketamine Story: Transforming Treatment for Mood Disorders and Pain Join a free webinar on February 5, 2024, at 6 PM PST, to explore the transformative role of ketamine in modern healthcare. The event titled 'The Ketamine Story: Transforming Treatment for Mood Disorders and Pain' features a panel of distinguished experts, including Drs. Sam Ko, Glareh Imani, and Ray Rivas, who will delve into the past, present, and future of ketamine therapy. This insightful webinar is essential for individuals interested in ketamine therapy, catering to a wide audience with varying levels of understanding in this transformative treatment. Ketamine Therapy Transformative Medical Care Mood Disorders Pain Management Webinar
Published on 12/21/2024 at 01:30, 17 hours 15 minutes ago Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 15 minutes ago iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 40 minutes ago Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/20/2024 at 23:30, 19 hours 15 minutes ago Boron One Announces Extension to Early Warrant Exercise Incentive Program
Published on 12/21/2024 at 00:51, 17 hours 54 minutes ago Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/20/2024 at 19:10, 23 hours 34 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 49 minutes ago CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/21/2024 at 12:17, 6 hours 27 minutes ago AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 17:55, 1 day ago Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 4 hours ago Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago Share capital decrease by way of treasury shares cancellation